Defects in the TAP1 gene, a component of the antigen processing machinery, and the HLA Class I genes (HLA-A, HLA-B, and HLA-C) enable tumor cells to evade immune destruction by CD8+ T cells due to impaired presentation of tumor antigens. Here, CD8A is linked to neoplasm.